Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Diagnostic Testing for Sleep Apnea in Heart Failure
Author(s): Marat Fudim Added: 10 months ago
In this short interview, Dr Marat Fudim offers a preview of his upcoming manuscript, set to appear in the Sleep Disordered Breathing in Heart Failure special focus collection in Cardiac Failure Review. He discusses the evolving role of home sleep testing in diagnosing sleep apnea in patients with heart failure, addressing key considerations in clinical workflows and patient selection.Watch now to… View more

Heart Failure
Emerging Toxicities, Translational Research and Reverse Cardio-oncology
Author(s): Massimiliano Camilli , Luca Maggio , Lorenzo Tinti , et al Added: 1 year ago

CV Disease in Special Populations

Heart Failure
Dan Lenihan
Research Area(s) / Expertise: Job title: Cardio-oncologist
Dr Dan Lenihan is a cardio-oncologist specialising in cardiology, heart disease and advanced heart failure, atSaint Francis Healthcare System, Cape Girardeau, US.He is a co-Founder and Board Member of the International Cardio-Oncology Society (ICOS), which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy.He is… View more
Start date: May 11, 2024 End date: May 11, 2024
Radcliffe Medical Education is hosting a symposium entitled 'Challenges in ATTR Amyloidosis: An Expert Debate' at theHeart Failure Association (HFA)in Lisbon, PT, on Saturday 11 May 2024 at 12:30 - 13:30 UTC+1.OverviewIn this symposium we join Prof Thibaud Damy (Creteil, FR), Dr Esther González López (Madrid, SP), Dr João R. Agostinho (Lisbon, PT) and Dr Ahmad Masri (Portland, USA) for a… View more

Heart Failure
Two-dimensional Echocardiography
Author(s): Reynald Evan R Tugade , Zabrina Rodriguez , Rommel Yap , et al Added: 1 year ago

Heart Failure
Aficamten Effective in Mildly Symptomatic oHCM Patients
Added: 5 months ago Source:  Radcliffe Cardiology
New data from the SEQUOIA-HCM trial suggests that the cardiac myosin inhibitor aficamten provides significant clinical benefits for patients with obstructive hypertrophic cardiomyopathy (oHCM) and mild symptoms, with an efficacy and safety profile comparable to that seen in patients with more advanced symptoms.¹Aficamten is a novel, selective cardiac myosin inhibitor that works by reducing the… View more

Inherited and Congenital Cardiac Conditions

Heart Failure
Biomarkers for Early Detection and Prognosis of Heart Failure
Author(s): Moza A Alzaabi , Amin Abdelsalam , Majid Alhammadi , et al Added: 1 year ago

Heart Failure
Increasing VA-ECMO Flow Does Not Typically Raise Pulmonary Capillary Wedge Pressure in Cardiogenic Shock
Added: 7 months ago Source:  Radcliffe Cardiology
New research challenges the common assumption that high flow rates during venoarterial extracorporeal membrane oxygenation (VA-ECMO) increase pulmonary capillary wedge pressure (PCWP) and the risk of pulmonary oedema in patients with cardiogenic shock. The ECMO-Flow trial found that increasing VA-ECMO flow often has a neutral or even beneficial effect on PCWP, despite raising left ventricular… View more

Imaging & Diagnostics

Heart Failure
Development of Small-molecule SERCA Stimulators
Author(s): Antonio Zaza , Marcella Rocchetti Added: 9 months ago

Heart Failure
Precision in Practice: Navigating Amyloidosis Diagnosis and Referral
Start date: May 17, 2025 End date: May 17, 2025
Radcliffe Medical Education is hosting a symposium entitled 'Precision in Practice: Navigating Amyloidosis Diagnosis and Referral' at theHeart Failure Association (HFA)in Serbia, RS, on Saturday 17 May 2025 at 12:30 - 13:30 CEST.OverviewIn this symposium we join Dr Margot Davis (Vancouver, CA), Prof Fabian Knebel (Berlin, DE), Dr AleksandarAleksandrov (Berlin, DE) and Prof Olivier Lairez … View more

Heart Failure